Skip to content
Preprint

DNA Methylation Profiling in Melanoma: From Lesion Classification to Therapeutic Stratification

Aug 2026 · 0 citations · 10 references
Biology Computer Science

TL;DR

It is demonstrated that methylation-based models can capture both diagnostic identity and clinically relevant disease stratification, supporting DNA methylation as a promising biomarker for further validation and potential clinical translation.

Abstract

DNA methylation provides a stable record of cellular identity, capturing epigenetic programs that distinguish specialized cell states despite a shared genome. Because malignant transformation and tumour progression are accompanied by extensive epigenetic remodeling, we hypothesized that the methylome of melanocytic lesions contains biologically and clinically relevant information for both diagnosis and disease progression. In a cohort of 1,001 tissue samples prospectively collected across eight German university hospitals profiled using Illumina Infinium MethylationEPIC arrays, we compared machine-learning models based on selected Cytosine phosphate Guanine (CpG) methylation sites with models incorporating biology-guided features, including epigenetic age acceleration, cell type composition and copy-number variation burden. In an external test set, the best diagnostic classifier was CpG-based and distinguished melanocytic nevi, noninvasive melanoma and invasive melanoma with a macro-averaged area under the receiver operating characteristic curve of 0.919 (95% CI: 0.878 to 0.952). Notably, across CpGs most strongly hyper- and hypomethylated between NV and IM, NIM showed an intermediate methylation profile, providing a molecular correlate of its diagnostic complexity. The best model for clinically relevant treatment group prediction, with AJCC stages grouped according to guideline-based management recommendations, relied on biology-guided features and achieved a macro-averaged mean absolute error of 0.627 (95% CI: 0.477 to 0.808). Together, these findings demonstrate that methylation-based models can capture both diagnostic identity and clinically relevant disease stratification, supporting DNA methylation as a promising biomarker for further validation and potential clinical translation.

View source

Similar papers

Open access Sep 2026

DNA methylation status at diagnosis in MDS predicts response to azacitidine.

Epigenetic signatures at distal genomic elements provide superior predictive power for AZA response compared to promoter-centric or transcriptional analyses, and establish a robust framework for personalized treatment strategies in MDS.

Qin Yang, M. Torres-Martín, M. Taguchi et al. · 0 citations
Oct 2026

Whole-genome DNA methylation analysis reveals distinct subtype characteristics in epithelial ovarian cancer.

The subtype-specific DNA methylation markers identified in this study accurately reflect the distinct histological features of each EOC subtype and hold promise for application in subtype classification and prognosis prediction, thereby providing a scientific foundation for future clinical interventions in EOC.

Qiao-Lin Ren, Ying-Qing Deng, Cai-Yan Zhong et al. · 0 citations
Open access Sep 2026

Genome-wide DNA methylation landscapes in gallbladder carcinoma: revealing shared and distinct epigenetic signatures across subtypes.

BACKGROUND Gallbladder cancer is an aggressive malignancy with poor survival rates, there are biologically distinct subtypes, yet genome-wide epigenetic differences remain poorly understood. This study was designed as an exploratory investigation of subtype-specific DNA methylation patterns. METHODS The study include...

D. Singh, Shubham K. Talware, Shridhar Mishra et al. · 0 citations
Open access Sep 2026

Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer

ABSTRACT Epithelial ovarian cancer (EOC) is a heterogenous disease with frequent late-stage diagnosis and high mortality rates, for which no reliable screening tests exist. In recent years, epigenetic biomarkers in the form of DNA methylation in CpG-rich regions have gained increased attention in the scientific communi...

Hugo Swenson, Ella Ittner, Lucas Werner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.